![]() ![]() DLA reserves the right to issue the solicitation before or after the projected solicitation date. The current projected solicitation date is November of 2022. All information provided in support of this product, including SDS and. 2 This product is provided as delivered and specified by the issuing Pharmacopoeia. 1 It is an anti-inflammatory agent and has been considered as vasoconstrictor in nature. ![]() Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. Clobetasol propionate is a fluorinated corticosteroid. All sources may submit a proposal which shall be considered by the agency.Ī copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at and Interested parties should contact Ryan Ferry email: for any questions/comments. ![]() This is a commercial item and will be solicited using FAR part 12. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. This will be an unrestricted and fully competitive acquisition. Procurement details follow.Ĭlobetasol Propionate 0.05% Solution in 25ML and 50ML bottles. The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Clobetasol Propionate. ![]()
0 Comments
Leave a Reply. |